博研生物为您现货提供*的产品与服务，本中心产品齐全，保证实验的有效性，提供，是您科研实验产品的一站式平台，咨询。！

产品名称：Anti-Cyclin B1抗体,周期素B1抗体
中文名称：周期素B1抗体
英文名称：Anti-Cyclin B1
产品编号：BYK-0572R
产品别名：CCNB 1; CCNB; CCNB1; CCNB1_HUMAN; G2 mitotic specific cyclin B1; G2/mitotic-specific cyclin-B1.

本公司另供应“周期素B1抗体”的标记有：Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647 AP APC Biotin Cy3 Cy5 Cy5.5 Cy7 FITC Gold HRP PE PE-Cy3 PE-CY5 PE-CY5.5 PE-CY7 RBITC.
产品规格：100ug/200ug
产品浓度： 1mg/1ml
抗体来源：兔源、鼠源、其他
克 隆：单克隆抗体、多克隆抗体
抗体类型：一抗
性 状： 冻干粉或液体
保存条件：Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

Anti-Cyclin B1抗体,周期素B1抗体技术说明，产品*，由于篇幅原因，更多信息请：

Anti-PTPRJ/CD148/DEP1  CD148抗体
Anti-PTP-1B（Protein tyrosine phosphatase non receptor type 1）  蛋白*磷酸酶-1B
Anti-Parvalbumin  微白蛋白/细小清蛋白抗体
Anti-PTTG（Pituitary Tumor Transforming Gene）  垂体肿瘤转化基因抗体
Anti-Rad51  Rad51抗体
Anti-Rad52（RAD52 homolog ）  Rad52抗体
Anti-RAD51C抗体
anti-RAP1A （RAS-related protein-1a precursor）  抗Rap1A抗体
Anti-phospho c-Raf（pSer338/pTyr340）  磷酸化原癌基因c-Raf抗体
Anti-RAR-α （Retinoic acid Receptor-α）  维甲酸受体-α 抗体
Anti-RAR-β（Retinoic acid -R-β）  维甲酸受体-β抗体
Anti-RASSF1A（Ras association domain family 1A）  Ras相关区域家族1A抗体
Anti-Pan-ras  抗Pan ras抗体
Anti-Rat IgA  大鼠IgA抗体
Anti-RELN（Reelin）  络丝蛋白抗体
Anti-CPSA（complex edprostate specific antigen mouse monoclonal）   鼠抗人复合前列腺特异性抗原单克隆抗体
Anti-PSAP/PAP（Prostate Specific Acidic Phosphatase）  前列腺酸性磷酸酶抗体
Anti-PSCA （Prostate Stem Cell Anti-gen）  抗前列腺干细胞抗原抗体
Anti-PSD-95  突触后密度蛋白95抗体

产品介绍：

The protein encoded by this gene is a regulatory protein involved in mitosis. The gene product complexes with p34（cdc2） to form the maturation-promoting factor （MPF）. Two alternative transcripts have been found, a constitutively expressed transcript and a cell cycle-regulated transcript, that is expressed predominantly during G2/M phase. The different transcripts result from the use of alternate transcription initiation sites.